Post Polycythemia Vera Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib
Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Darlinghurst, New South Wales, Australia
  • +109 more
2022-03-15
Mar 15, 2022
C
A Safety Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib With Concomitant Luspatercept for Subjects With Anemia
Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Aurora, Colorado
  • +34 more
2022-02-16
Feb 16, 2022
N
A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis - 2011
Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
2021-07-09
Jul 9, 2021
S
Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - 2014
Completed
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +5 more
2019-01-31
Jan 31, 2019